FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.6181
-0.0939 (-13.19%)
At close: Jun 27, 2025, 4:00 PM
0.6496
+0.0315 (5.10%)
After-hours: Jun 27, 2025, 7:34 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $24.26 million as of June 27, 2025. Its market cap has decreased by -93.50% in one year.
Market Cap
24.26M
Enterprise Value
22.70M
1-Year Change
-93.50%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $24.26M, a decrease of -97.43%. That is a compound annual growth rate of -92.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 28.18M | -59.85% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.00B |
| Johnson & Johnson | 365.89B |
| AbbVie | 330.42B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.78B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.04B |
| AstraZeneca | 216.45B |